Results 191 to 200 of about 25,935 (265)

Data from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

Lena Fischer‐Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger N. Lode, Dennis Görlich, Andréas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rössig   +20 more
openalex   +1 more source

Development of a Novel Extracellular Vesicle-Based Biomarker Approach for Pediatric High-Grade Glioma. [PDF]

J Extracell Biol
Fernandez Garcia A, Iyer P, Ashi P, Tella I, Sangaraboina V, Bhagat D, Janarthanam C, Bargues-Carot A, Kanthasamy AG, Spoerer T, Golan ME, Stice SL, Funato K.   +12 more
europepmc   +1 more source

GD2-CAR-Engineered Microglia Exhibit Antitumor Effects in Organoids and Animal Models of Retinoblastoma. [PDF]

Invest Ophthalmol Vis Sci
Xu J, Gao Y, Wang J, Lyv M, Zhang Z, Cheng Y, Jin ZB.   +6 more
europepmc   +1 more source

Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma. [PDF]

Sci Transl Med
Giudice AM, Matlaga S, Roth SL, Pascual-Pasto G, Schürch PM, Rouin G, McIntyre B, Grothusen GP, Cresswell-Clay E, Shraim R, Groff D, Zecchino V, Lombardi S, Martinez D, Spruce LA, Brown EM, Fazelinia H, Henrickson SE, Nance J, Reynolds CP, Bosse KR.   +20 more
europepmc   +1 more source

Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies. [PDF]

Oncol Res
Kim MH, Huh B, Park JW, Park WJ.
europepmc   +1 more source

Low plasma volume LC-MS/MS quantification shows an increase of circulating GD2 and 3-OMD levels in relapsed high-risk neuroblastoma patients

M. Morini, S. Barco, N. Liessi, M.T. Gambaudo, A. Tassistro, A. Cafaro, C. Scarone, R. Barba, M. Fragola, S. Sorrentino, M. Conte, A. Garaventa, G. Cangemi   +12 more
openalex   +1 more source

Exploring the long-term use of ambroxol in Gaucher disease type 2: insights from two pediatric cases. [PDF]

Front Neurol
Aries C, Köhn A, Täuber K, Rudolph C, Böttcher T, Bauer P, Fischer S, Muschol N.   +7 more
europepmc   +1 more source

Myeloid derived suppressor cells in neuroblastoma: mechanisms of immune evasion and therapeutic opportunities. [PDF]

Front Immunol
Choo HS, Yu T, Pham T, Singh N, Joshi S.
europepmc   +1 more source

IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity. [PDF]

Mol Ther
Barragán Bravo GA, de la Cerda DA, Landoni E, Dholakia K, Humeniuk P, Caraballo Galva LD, Wang Y, Tian G, Yang B, Guo L, Wood MS, Rios X, Xu X, Courtney AN, Di Pierro EJ, Jacob J, Li YH, Adaikkalavan A, Watanabe N, Mao S, Miles G, Dotti G, Metelitsa LS.   +22 more
europepmc   +1 more source

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas [PDF]

Michelle Monje, Jasia Mahdi, Robbie G. Majzner, Kristen W. Yeom, Liora M. Schultz, Rebecca M. Richards, Valentin Barsan, Kun-Wei Song, Jen Kamens, Christina Baggott, Michael Kunicki, Skyler P. Rietberg, Alexandria Sung Lim, Agnes Reschke, Sharon Mavroukakis, Emily Egeler, Jennifer Moon, Shabnum Patel, Harshini Chinnasamy, Courtney Erickson, Ashley Jacobs, Allison K. Duh, Ramya Tunuguntla, Dorota D. Klysz, Carley Fowler, Sean Green, Barbara Beebe, Casey Carr, Michelle Fujimoto, Annie Kathleen Brown, Ann-Louise G. Petersen, Catherine McIntyre, Aman Siddiqui, Nadia Lepori‐Bui, Katlin Villar, Kymhuynh Pham, Rachel Bove, Eric Musa, Warren D. Reynolds, Adam Kuo, Snehit Prabhu, Lindsey Rasmussen, Timothy T. Cornell, Sonia Partap, Paul G. Fisher, Cynthia Campen, Gerald A. Grant, Laura M. Prolo, Xiaobu Ye, Bita Sahaf, Kara L. Davis, Steven A. Feldman, Sneha Ramakrishna, Crystal L. Mackall   +53 more
openalex   +1 more source